Andrew Thorpe, a partner in Orrick's San Francisco office, is a member of the Corporate group. Andrew’s practice focuses on securities regulation, public offerings, mergers and acquisitions and corporate governance.

His diverse industry experience spans semiconductors, software, fintech, life sciences, medical devices, clean technology, financial services, telecommunications and internet.

Andrew is one of the top IPO counsels to issuers, according to statistics from IPO Vital Signs. Andrew has been involved in over 40 IPOs. In the Legal 500 rankings, it was noted that Andrew "is great to work with:  he's knowledgeable, has excellent capital markets and regulatory experience, and is creative, smart and always keeps his cool."

Andrew provides clients with his valuable perspective from having extensive experience on all sides of the table in capital markets transactions – issuer, underwriter and the SEC. Prior to entering private practice, Andrew worked in the Division of Corporation Finance of the Securities and Exchange Commission, where he was responsible for reviewing public companies' Securities Act and Exchange Act filings. From January 2001 to April 2005, Andrew served as special counsel with the Office of Rulemaking within the Division of Corporation Finance. While in this position, he played a significant role in drafting many of the regulations emanating from the Division, including those mandated by the Sarbanes-Oxley Act of 2002, as well as Securities Act Reform.

Before joining Orrick, Andrew was a partner with Morrison & Foerster LLP.

  • A representative listing of Andrew's recent transactions include:

    • Advised Ooma, Inc. (NYSE: OOMA), a smart business and home communications company, as issuer's counsel on selling stockholder follow-on offering of US$29.1 million (March 2017).
    • Advised Ooma, Inc. (NYSE: OOMA) as issuer's counsel on selling stockholder follow-on offering of US$28.3 million (January 2017).
    • Advised JMP Securities LLC as underwriter's counsel on US$18.6 million follow-on offering of AxoGen, Inc. (NASDAQ: AXGN), a regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration (2016).
    • Advised JMP Securities LLC as underwriter's counsel on US$44.9 million follow-on offering of Impac Mortgage Holdings, Inc. (NYSE: IMH), a nationwide residential mortgage lender (2016).
    • Advised Ellie Mae, Inc. (NYSE: ELLI), a SaaS company for the residential mortgage industry, as issuer's counsel on US$284.6 million follow-on public offering (2016).
    • Advised JMP Securities LLC as financial advisor's counsel on the $85.2 million acquisition of JAVELIN Mortgage Investment Corp. (NYSE: JMI) by ARMOUR Residential REIT, Inc. (NYSE: ARR) (2016).
    • Advised Ooma, Inc. (NYSE: OOMA), a smart business and home communications company, as issuer's counsel on $65.0 million initial public offering (2015).
    • Advised the Bitcoin Investment Trust (OTCQX: GBTC) on its OTCQX quotation and becoming the first publicly-traded bitcoin fund (2015).
    • Advised JMP Group on its corporate reorganization and conversion into a publicly-traded partnership (2015).
    • Advised Morgan Stanley, Bank of America Merrill Lynch, J.P. Morgan and Deutsche Bank Securities as underwriter's counsel on $230 million initial public offering of On Deck Capital, Inc. (NYSE: ONDK), an online lending platform for small business lending (2014).
    • Advised FIMI Opportunity Funds, an Israeli private equity firm, on $25.6 million cross-border cash tender offer for ordinary shares of Gilat Satellite Networks Ltd. (NASDAQ: GILT) (2014).
    • Advised JMP Securities as underwriter's counsel on $18 million follow-on offering and Nasdaq listing of AxoGen, Inc. (NASDAQ: AXGN), a regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration (2013).
    • Advised Marrone Bio Innovations, Inc. (NASDAQ: MBII), a provider of bio-based pest management and plant health products, as issuer's counsel on $65.5 million initial public offering (2013).
    • Advised Kamada Ltd. (NASDAQ:KMDA), a Tel Aviv Stock Exchange listed biopharmaceutical company, as issuer's counsel on $51.6 million U.S. initial public offering on Nasdaq (2013).
    • Advised Restoration Hardware Holdings, Inc. (NYSE: RH) as issuer's counsel on $498.7 million and $644.0 million follow-on offerings (2013).
    • Advised JMP Group Inc. (NYSE: JMP), a full service investment banking and asset management firm, as issuer's counsel on $46 million offering of 8.0 percent Senior Notes due 2023 (2013).
    • Advised Restoration Hardware Holdings, Inc. (NYSE: RH) as issuer's counsel on $142.5 million initial public offering (2012).
    • Advised JMP Securities LLC as financial advisor's counsel on $41.5 million acquisition of Network Equipment Technologies, Inc. (NASDAQ: NWK) by Sonus Networks, Inc. (NASDAQ: SONS) (2012).
    • Advised InvenSense, Inc. (NYSE: INVN), a leading provider of motion processing solutions for consumer electronics, as issuer's counsel on $98 million follow-on offering (2012).
    • Advised InvenSense, Inc. (NYSE: INVN) as issuer's counsel on $86 million initial public offering (2011).
    • Advised FBR Capital Markets, Inc. as underwriter's counsel on $80.5 million follow-on offering of Hanmi Financial Corp. (NASDAQ: HAFC), a financial holding company with a Korean-American community bank (2011).
    • Advised JMP Securities LLC as placement agent's counsel on $6.4 million registered direct offering of Altair Nanotechnologies, Inc. (NASDAQ: ALTI), a provider of nano-lithium titanate battery products (2011).
    • Advised Neurogesx, Inc. (NASDAQ: NSGX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, as issuer’s counsel on $20 million PIPE offering (2011).
    • Advised JMP Securities LLC as financial advisor's counsel on $110 million acquisition of United PanAm Financial Corp. (PINK: UPFC) by an entity controlled by Guillermo Bron, Chairman of the Board of Directors of UPFC, and by affiliates of Pine Brook Road Partners, LLC (2011).
    • Advised JMP Group Inc. (NYSE: JMP), a full-service investment banking and asset management firm, as issuer's counsel on “at-the-market” offering of up to 3,000,000 shares of common stock (2011).
    • Advised CleanEnergy Fuels Corp. (NASDAQ: CLNE), a provider of natural gas solutions of vehicle fleets primarily in the United States, as issuer's counsel in $39.8 million follow-on offering (2010).
    • Advised JMP Securities LLC as financial advisor's counsel on $57.5 million strategic investment in Altair Nanotechnologies, Inc. (NASDAQ: ALTI) by Canon Investment Holdings Limited (2010).
    • Advised CleanEnergy Fuels Corp. (NASDAQ: CLNE) on acquisition of IMW Industries, Ltd., a manufacturer and servicer of advanced natural gas fueling compressors and related equipment, for $125 million plus a cash earn-out arrangement (2010).
    • Advised MediGuide Inc., a privately owned Israeli medical device company, on acquisition by St. Jude Medical, Inc. (NYSE: STJ) for $283 million plus the assumption of debt (2010).

Insights

News